Mobilization and Handling of Stem Cells for Transplant From Healthy Volunteers With Sickle Cell Trait

NCT00005782 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

12

Enrollment

NIH

Sponsor class

Conditions

Sickle Cell Trait

Interventions

DRUG: Granulocyte colony-stimulating factor
PROCEDURE: Leukapheresis

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)